These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 620934)

  • 21. Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy.
    Peterson BA; Bloomfield CD
    Cancer; 1977 Aug; 40(2):647-52. PubMed ID: 890652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of acute nonlymphocytic leukemia: I. Clinical aspects.
    Preisler HD; Higby DJ
    N Y State J Med; 1979 May; 79(6):879-84. PubMed ID: 286190
    [No Abstract]   [Full Text] [Related]  

  • 23. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective erythroid aplasia during therapy for acute lymphoblastic leukemia.
    Sallan SE; Buchanan GR
    Pediatrics; 1977 Jun; 59(6):895-8. PubMed ID: 266692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Achievements in the treatment of leukemia and lymphoma].
    Berchenal J
    Klin Med (Mosk); 1973 Jun; 51(6):15-20. PubMed ID: 4590258
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of leukemia in the elderly (author's transl)].
    Höcker P
    Aktuelle Gerontol; 1979 Jan; 9(1):27-33. PubMed ID: 33567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled clinical trial to evaluate a protected environment and prophylactic antibiotic program in the treatment of adult acute leukemia.
    Freireich EJ; Bodey GP; Rodriguez V; Gehan EA; Smith T; Hester JP; McCredie KB; Rawson RW
    Trans Assoc Am Physicians; 1975; 88():109-19. PubMed ID: 772923
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 30. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission.
    Brincker H
    Cancer Treat Rep; 1985 Jan; 69(1):5-11. PubMed ID: 3881178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of acute leukemia in adults.
    Ellison RR
    Med Pediatr Oncol; 1975; 1(2):149-58. PubMed ID: 778572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
    Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA
    Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
    Hersh EM; Gutterman JU; Mavligit GM; McCredie KB; Burgess MA; Matthews A; Freireich EJ
    J Clin Invest; 1974 Aug; 54(2):401-8. PubMed ID: 4527189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
    Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
    Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult acute nonlymphocytic leukemias.
    Dabich L
    Med Clin North Am; 1980 Jul; 64(4):683-704. PubMed ID: 6995730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute leukemia of adult age. Therapeutic strategy].
    Wendt F; Hackländer T
    Dtsch Med Wochenschr; 1978 Apr; 103(14):626-31. PubMed ID: 346334
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood component therapy. Supportive therapy for acute leukemia (author's transl)].
    Maekawa I; Sakurada K; Shiraishi T
    Hokkaido Igaku Zasshi; 1977 Jul; 52(4):381-6. PubMed ID: 336501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.